BBY
56
-2
SBUX
41
-3
DNB
50
-4
UNH
53
-3
PNC
57
-2
DIS
60
2
PEP
47
-3
LEN
55
-9
IBM
81
3
MNST
49
-3
DOW
58
-5
AEP
58
2
COST
56
3
CHD
54
6
MDT
53
-2
HON
47
-12
AVY
53
-9
ORLY
57
-3
ADT
32
9
LYB
46
-4
BBY
56
-2
SBUX
41
-3
DNB
50
-4
UNH
53
-3
PNC
57
-2
DIS
60
2
PEP
47
-3
LEN
55
-9
IBM
81
3
MNST
49
-3
DOW
58
-5
AEP
58
2
COST
56
3
CHD
54
6
MDT
53
-2
HON
47
-12
AVY
53
-9
ORLY
57
-3
ADT
32
9
LYB
46
-4
Financhill
Back

FT Canadian Capital Strength ETF Comm Vs. Apellis Pharmaceuticals Industry Stock Comparison

Buy
55

FST.TO
FT Canadian Capital Strength ETF Comm

Last Price:
52.89
Seasonality Move:
0.71%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Buy
55
FT Canadian Capital Strength ETF Comm (FST.TO) is a Buy

Is FT Canadian Capital Strength ETF Comm a Buy, Sell or Hold?

  • The current FT Canadian Capital Strength ETF Comm [FST.TO] share price is $52.89. The Score for FST.TO is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • FST.TO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

FST.TO Stock Price Chart

What is FT Canadian Capital Strength ETF Comm's stock price today?

  • The FT Canadian Capital Strength ETF Comm share price today is $52.89
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FST.TO is experiencing slight buying pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

FST.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.28 Buy
Relative Strength Index (14 RSI): 62.22 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.48 - 52.66) Buy
Bollinger Bands (100): (49.67 - 51.89) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

FST.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 52.22 Buy
20-day SMA: 52.01 Buy
50-day SMA: 51.64 Buy
200-day SMA: 48.73 Buy
8-day EMA: 52.35 Buy
20-day EMA: 52.01 Buy
50-day EMA: 51.53 Buy
200-day EMA: 49.04 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

FT Canadian Capital Strength ETF Comm Earnings Growth & FST.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

FT Canadian Capital Strength ETF Comm Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):